Patent · US Active

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

US10683293B2 · kind B2 · utility

2Cited by
3References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2015
Grant dateJun 16, 2020
Priority date—
Expiry dateJul 31, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.